These findings further established HMGB1 as a key driver of MM cell aggressiveness [30], and expanded on earlier research that first reported how EP suppressed the malignant phenotype of human mesothelioma by targeting HMGB1 [31]. Here, HMGB1 is linked to Miyoshi myopathy.